Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,783 | 71,847 | 76,416 | 88,740 | 122,754 |
| Marketable Securities | 7,035 | 15,554 | 23,649 | 18,185 | 19,024 |
| Receivables | 14,029 | 5,380 | 60,129 | 40,401 | 21,793 |
| Other current assets | 0 | 0 | -1 | 0 | 0 |
| TOTAL | $52,848 | $92,781 | $160,193 | $147,326 | $163,571 |
| Non-Current Assets | |||||
| PPE Net | 4,928 | 5,554 | 6,842 | 9,000 | 12,037 |
| Intangibles | 0 | 0 | 450 | 1,639 | 52,284 |
| Other Non-Current Assets | 13,184 | 21,841 | 31,866 | 61,040 | 88,585 |
| TOTAL | $18,113 | $27,396 | $39,159 | $71,680 | $152,905 |
| Total Assets | $70,960 | $120,177 | $199,352 | $219,005 | $316,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,019 | 17,321 | 18,419 | 22,032 | 33,805 |
| Other current liabilities | 21,250 | 17,702 | 18,133 | 14,610 | 45,920 |
| TOTAL | $41,465 | $35,690 | $42,899 | $43,554 | $94,513 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,196 | 667 | 6,348 | 6,912 | 14,789 |
| Other Non-Current Liabilities | 54,052 | 71,871 | 85,535 | 101,024 | 58,833 |
| TOTAL | $54,052 | $74,928 | $100,281 | $118,397 | $94,848 |
| Total Liabilities | $95,516 | $110,618 | $143,180 | $161,951 | $189,361 |
| Shareholders' Equity | |||||
| Common Shares | 5,303 | 4,536 | 4,377 | 4,226 | 4,706 |
| Retained earnings | -437,133 | -364,552 | -356,426 | -286,804 | -259,577 |
| Other shareholders' equity | -54,374 | -53,503 | -7,657 | -60,354 | -61,940 |
| TOTAL | $-24,556 | $9,559 | $56,173 | $57,054 | $127,112 |
| Total Liabilities And Equity | $70,960 | $120,177 | $199,352 | $219,005 | $316,473 |